MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$597K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Foreign currency transaction (ga...
Inventories
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Net income (loss)
Payments for patent costs
Purchases of property and equipm...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-4,418
-5,129
-5,497
-3,170
Amortization of debt discount
282
291
249
190
Amortization of patents
62
61
262
-
Depreciation and amortization
576
-
97
364
Depreciation
-
289
-
-
Amortization of right-of-use asset
27
26
26
109
Loss on abandoned patents
64
98
-
176
Write off of inventory
-
-
0
0
Bad debt expense (recovery)
241
-1
23
8
Loss on abandoned patents
-
-
559
-
Write off of fixed assets
-
-
104
-
Stock-based compensation
368
544
886
488
Foreign currency transaction (gains) losses
-911
-1,228
193
-64
Accounts receivable
-67
-310
137
-303
Inventories
-789
-723
1,293
322
Prepaid expenses and other current assets
-516
-129
-802
908
Other assets
0
-1
-2
-
Accounts payable and accrued expenses
221
92
-539
193
Net cash used in operating activities
-583
-1,162
-4,825
-2,577
Purchases of property and equipment
14
11
108
17
Disposals of property and equipment
59
26
76
-
Payments for patent costs
38
61
259
-72
Net cash used in investing activities
7
-46
-291
55
Proceeds from long-term debt
-
-
2,478
-
Proceeds from rights offering, net
-
-
5,392
-
Cash for exercise of warrants, net
-
-
0
0
Proceeds from rights offering, net of fees incurred
-
-
-
0
Net cash provided by financing activities
-
-
2,478
0
Effect of exchange rates on cash
176
-228
1,351
-146
Net change in cash, cash equivalents, and restricted cash
-400
-1,436
-1,287
-2,668
Cash, cash equivalents, and restricted cash as of beginning of period
6,335
7,771
9,058
9,764
Cash, cash equivalents, and restricted cash as of end of period
5,935
6,335
7,771
9,058
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Disposals of property and
equipment
$59K
Effect of exchange
rates on cash
$176K
(-38.25%↓ Y/Y)
Net cash used in
investing activities
$7K
(103.91%↑ Y/Y)
Canceled cashflow
$52K
Net change in cash,
cash equivalents,...
-$400K
(-120.39%↓ Y/Y)
Canceled cashflow
$183K
Foreign currency
transaction (gains) losses
-$911K
(-109.91%↓ Y/Y)
Inventories
-$789K
(-185.30%↓ Y/Y)
Depreciation and
amortization
$576K
(-25.49%↓ Y/Y)
Prepaid expenses and
other current assets
-$516K
(72.80%↑ Y/Y)
Stock-based compensation
$368K
(-73.54%↓ Y/Y)
Amortization of debt discount
$282K
(-25.98%↓ Y/Y)
Bad debt expense
(recovery)
$241K
(2577.78%↑ Y/Y)
Accounts payable and
accrued expenses
$221K
(161.39%↑ Y/Y)
Accounts receivable
-$67K
(73.93%↑ Y/Y)
Loss on abandoned
patents
$64K
Amortization of patents
$62K
Amortization of right-of-use
asset
$27K
(-62.50%↓ Y/Y)
Payments for patent costs
$38K
(-72.86%↓ Y/Y)
Purchases of property and
equipment
$14K
(-64.10%↓ Y/Y)
Net cash used in
operating activities
-$583K
(88.28%↑ Y/Y)
Canceled cashflow
$4,124K
Net income (loss)
-$4,418K
(-1042.00%↓ Y/Y)
something is missing
-$289K
Buy us a coffee
Cytosorbents Corp (CTSO)
Cytosorbents Corp (CTSO)